# OnCo record chris-parker (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/chris-parker/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "chris-parker" ;
  schema:name "Chris C. Parker"@en ;
  schema:description "London radiation oncologist who led ALSYMPCA, the trial that showed radium-223 lengthens survival in prostate cancer that has spread to bone, and RADICALS-RT, which showed radiotherapy after prostatectomy can safely wait until the PSA rises."@en ;
  schema:url <https://onco.cc/people/chris-parker/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "prostate", "radiotherapy", "trialist" ;
  schema:jobTitle "Clinical oncologist, The Royal Marsden and The Institute of Cancer Research" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate-bcr/>, <https://onco.cc/cancers/prostate/> ;
  onco:institutions <https://onco.cc/institutions/royal-marsden/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-radicals-rt-lancet-2020/>, <https://onco.cc/key-papers/paper-alsympca-radium-223-nejm-2013/> ;
  schema:affiliation <https://onco.cc/institutions/royal-marsden/> .